Two birds with one stone: Targeting METTL3 ameliorates doxorubicin-induced endothelial premature senescence and atherosclerosis while potentiating its antitumor efficacy

衰老 癌症研究 医学 细胞衰老 生物 免疫学 药理学 化学 细胞生物学 内皮干细胞
作者
Hao Tang,Jia Shen,Weining Yuan,Qingbo Fan,Wanjun Zhang,Runhua Li,Xiaojun Hu,Xiaohan Ma,Yingchao Shi,Zhen Li,Yu Han,Wei Jiang,Junyue Xing,Datun Qi,Dongdong Jian,Xiaolei Cheng,Liguo Jian
出处
期刊:Free Radical Biology and Medicine [Elsevier BV]
卷期号:252: 525-540 被引量:1
标识
DOI:10.1016/j.freeradbiomed.2026.05.290
摘要

Emerging evidence suggests that cancer survivors who have undergone anthracycline therapy frequently experience late-onset atherosclerosis. However, the mechanisms underlying this phenomenon and potential preventive strategies remain largely unexplored. In this study, we developed a mouse model to replicate doxorubicin (Dox)-induced atherosclerotic lesions. Given the established role of the RNA methyltransferase METTL3 in both atherogenesis and tumorigenesis, we conducted a comprehensive investigation to assess whether targeting METTL3 could mitigate Dox-induced atherosclerosis and enhance the efficacy of Dox in inhibiting tumor progression. Our findings reveal that Dox administration promotes vascular endothelial premature senescence and atherosclerosis, to a large extent by upregulating the expression of METTL3 and its substrate genes, particularly those encoding senescence-associated secreted proteins. To translate METTL3 as a therapeutic target, we developed and characterized an endothelium-targeted (achieved by coating with CD31 antibodies) nanoparticle loaded with the METTL3 inhibitor STM2457 (endothelium-targeted METTL3 nano-inhibitor, ETMN). As anticipated, ETMN effectively protects murine blood vessels against Dox-aggravated endothelial senescence and inflammation, as well as atheroma formation. Furthermore, ETMN, with enhanced enrichment in tumor allografts, significantly potentiates Dox's tumoricidal activity by attenuating METTL3 oncogenic signaling. In summary, our work offers a practical solution for addressing Dox therapy-related atherosclerosis, providing dual benefits and advancing the treatment and management of cancer patients undergoing anthracycline therapy. This study investigates the mechanism of doxorubicin (Dox)-induced atherosclerosis in cancer survivors and develops a targeted therapeutic strategy. We reveal that Dox promotes vascular endothelial senescence and atherogenesis by upregulating the RNA methyltransferase METTL3. An endothelium-targeted METTL3 nano-inhibitor (ETMN) is shown to concurrently alleviate Dox-accelerated atherosclerosis and potentiate its anti-tumor efficacy, offering a "two birds with one stone" approach. • RNA methyltransferase METTL3 is identified as a key mediator of doxorubicin-induced endothelial senescence and atherosclerosis. • An endothelium-targeted nanoparticle (ETMN) is developed for the specific delivery of the METTL3 inhibitor STM2457 to diseased vasculature and tumors. • ETMN co-administration alleviates doxorubicin-aggravated atherosclerotic plaque formation while simultaneously enhancing its anti-tumor efficacy. • Our work provides a promising therapeutic approach to decouple the anticancer benefits of anthracyclines from their detrimental vascular side effects.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
花样年华发布了新的文献求助10
3秒前
盟主完成签到 ,获得积分10
4秒前
沉静蓉发布了新的文献求助10
4秒前
超表面发布了新的文献求助10
4秒前
annie完成签到 ,获得积分10
6秒前
碧蓝老黑完成签到,获得积分10
6秒前
李健的应助被wm采纳,获得10
6秒前
8秒前
8秒前
8秒前
9秒前
思念变成王年年完成签到,获得积分10
9秒前
11秒前
坚强孤容发布了新的文献求助10
12秒前
LpmxRk发布了新的文献求助10
12秒前
任性子骞完成签到,获得积分10
12秒前
逐徒完成签到,获得积分10
13秒前
甜蜜的大象完成签到 ,获得积分10
13秒前
风起云涌完成签到,获得积分10
14秒前
赵荣吉发布了新的文献求助10
14秒前
哇啦发布了新的文献求助10
15秒前
SOBER发布了新的文献求助10
16秒前
babbo完成签到,获得积分10
17秒前
Arlen完成签到,获得积分10
17秒前
18秒前
SoftwarePrince完成签到 ,获得积分10
21秒前
PP发布了新的文献求助50
22秒前
彬彬完成签到 ,获得积分10
23秒前
英姑的应助被子夜歌采纳,获得30
24秒前
Cloud完成签到,获得积分0
25秒前
彭彭完成签到,获得积分10
25秒前
大水冲不进龙王庙完成签到 ,获得积分10
26秒前
Scofield完成签到 ,获得积分10
27秒前
吃花生酱的猫完成签到,获得积分10
28秒前
CJX完成签到,获得积分10
29秒前
赵正洁完成签到,获得积分10
30秒前
科研顺利完成签到,获得积分10
31秒前
Pan发布了新的文献求助10
31秒前
契说完成签到 ,获得积分10
34秒前
人间慈悲的应助被初一采纳,获得10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186806
求助须知:如何正确求助?哪些是违规求助? 9575125
关于积分的说明 21839712
捐赠科研通 7784453
什么是DOI,文献DOI怎么找? 3434839
关于科研通互助平台的介绍 2559245
邀请新用户注册赠送积分活动 2481712